AURA
Price
$7.00
Change
-$0.23 (-3.18%)
Updated
Jul 28, 04:59 PM (EDT)
Capitalization
433.41M
9 days until earnings call
DSGN
Price
$4.05
Change
+$0.03 (+0.75%)
Updated
Jul 28, 04:59 PM (EDT)
Capitalization
228.21M
14 days until earnings call
Interact to see
Advertisement

AURA vs DSGN

Header iconAURA vs DSGN Comparison
Open Charts AURA vs DSGNBanner chart's image
Aura Biosciences
Price$7.00
Change-$0.23 (-3.18%)
Volume$5.58K
Capitalization433.41M
Design Therapeutics
Price$4.05
Change+$0.03 (+0.75%)
Volume$200
Capitalization228.21M
AURA vs DSGN Comparison Chart in %
Loading...
AURA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DSGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AURA vs. DSGN commentary
Jul 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AURA is a Hold and DSGN is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 29, 2025
Stock price -- (AURA: $7.23 vs. DSGN: $4.02)
Brand notoriety: AURA and DSGN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AURA: 65% vs. DSGN: 57%
Market capitalization -- AURA: $448.29M vs. DSGN: $228.21M
AURA [@Biotechnology] is valued at $448.29M. DSGN’s [@Biotechnology] market capitalization is $228.21M. The market cap for tickers in the [@Biotechnology] industry ranges from $313.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.56B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AURA’s FA Score shows that 0 FA rating(s) are green whileDSGN’s FA Score has 0 green FA rating(s).

  • AURA’s FA Score: 0 green, 5 red.
  • DSGN’s FA Score: 0 green, 5 red.
According to our system of comparison, AURA is a better buy in the long-term than DSGN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AURA’s TA Score shows that 4 TA indicator(s) are bullish while DSGN’s TA Score has 5 bullish TA indicator(s).

  • AURA’s TA Score: 4 bullish, 3 bearish.
  • DSGN’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, both AURA and DSGN are a good buy in the short-term.

Price Growth

AURA (@Biotechnology) experienced а +7.75% price change this week, while DSGN (@Biotechnology) price change was +1.01% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.87%. For the same industry, the average monthly price growth was +20.93%, and the average quarterly price growth was +48.03%.

Reported Earning Dates

AURA is expected to report earnings on Aug 07, 2025.

DSGN is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Biotechnology (+6.87% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AURA($433M) has a higher market cap than DSGN($228M). AURA YTD gains are higher at: -12.044 vs. DSGN (-34.846). DSGN has higher annual earnings (EBITDA): -67.79M vs. AURA (-101.63M). DSGN has more cash in the bank: 230M vs. AURA (128M). DSGN has less debt than AURA: DSGN (2.14M) vs AURA (18.4M). AURA (0) and DSGN (0) have equivalent revenues.
AURADSGNAURA / DSGN
Capitalization433M228M190%
EBITDA-101.63M-67.79M150%
Gain YTD-12.044-34.84635%
P/E RatioN/AN/A-
Revenue00-
Total Cash128M230M56%
Total Debt18.4M2.14M859%
TECHNICAL ANALYSIS
Technical Analysis
AURADSGN
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
Momentum
ODDS (%)
Bullish Trend 4 days ago
87%
Bullish Trend 4 days ago
83%
MACD
ODDS (%)
Bullish Trend 4 days ago
83%
Bullish Trend 4 days ago
80%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
75%
Bullish Trend 4 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
75%
Bullish Trend 4 days ago
85%
Advances
ODDS (%)
Bullish Trend 4 days ago
77%
Bullish Trend 6 days ago
88%
Declines
ODDS (%)
Bearish Trend 14 days ago
83%
Bearish Trend 4 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
77%
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
Bullish Trend 4 days ago
77%
Bearish Trend 4 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
AURA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DSGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SDCH0.14N/A
+0.86%
SideChannel Inc.
ANOIX22.390.13
+0.58%
American Century Small Cap Growth Inv
PSSMX26.140.15
+0.58%
Principal SmallCap S&P 600 Index R3
GTLIX20.940.07
+0.34%
Glenmede Disciplined US Eq Ptf InstlShrs
AASOX17.270.01
+0.06%
Alger Small Cap Growth I-2

AURA and

Correlation & Price change

A.I.dvisor indicates that over the last year, AURA has been loosely correlated with IDYA. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if AURA jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AURA
1D Price
Change %
AURA100%
+2.41%
IDYA - AURA
52%
Loosely correlated
-1.33%
VRDN - AURA
51%
Loosely correlated
-1.20%
MGTX - AURA
51%
Loosely correlated
+0.72%
BEAM - AURA
51%
Loosely correlated
+3.68%
XNCR - AURA
49%
Loosely correlated
N/A
More

DSGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, DSGN has been loosely correlated with TCRT. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if DSGN jumps, then TCRT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DSGN
1D Price
Change %
DSGN100%
-0.50%
TCRT - DSGN
56%
Loosely correlated
-5.68%
VRDN - DSGN
49%
Loosely correlated
-1.20%
IDYA - DSGN
48%
Loosely correlated
-1.33%
KRYS - DSGN
47%
Loosely correlated
-1.59%
AURA - DSGN
44%
Loosely correlated
+2.41%
More